2018
Functional recovery after the systemic administration of mesenchymal stem cells in a rat model of neonatal hypoxia-ischemia.
Sakai T, Sasaki M, Kataoka-Sasaki Y, Oka S, Nakazaki M, Fukumura S, Kobayashi M, Tsutsumi H, Kocsis JD, Honmou O. Functional recovery after the systemic administration of mesenchymal stem cells in a rat model of neonatal hypoxia-ischemia. Journal Of Neurosurgery Pediatrics 2018, 22: 513-522. PMID: 30074448, DOI: 10.3171/2018.5.peds1845.Peer-Reviewed Original ResearchConceptsNeonatal hypoxia-ischemiaMesenchymal stem cellsHypoxia-ischemiaRat modelHypoxic-ischemic encephalopathyStem cellsCerebral palsyFunctional recoveryFunctional outcomeSystemic administrationIntravenous administrationAnimal studiesBrain volumePotential treatmentAdministrationPalsyCellsPatientsEncephalopathySynaptogenesis
2015
Corrigendum to “Intravenous mesenchymal stem cell administration exhibits therapeutic effects against 6-hydroxydopamine-induced dopaminergic neurodegeneration and glial activation in rats” [Neurosci. Lett. 584 (2015) 276–281]
Suzuki S, Kawamata J, Iwahara N, Matsumura A, Hisahara S, Matsushita T, Sasaki M, Honmou O, Shimohama S. Corrigendum to “Intravenous mesenchymal stem cell administration exhibits therapeutic effects against 6-hydroxydopamine-induced dopaminergic neurodegeneration and glial activation in rats” [Neurosci. Lett. 584 (2015) 276–281]. Neuroscience Letters 2015, 587: 5. DOI: 10.1016/j.neulet.2014.12.023.Peer-Reviewed Original Research